Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elemene + Oxaliplatin in Advanced Primary Liver Cancer
NCT03166553Unknown
- Start
- Nov 2016
- Primary completion
- May 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Elemene (2 arms). Primary endpoints: Objective Response Rate at 1 year and 1-Year Survival Rate. Status: unknown.
02
Drugs
Elemene
Beyond the preview
Go deeper on NCT03166553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03166553.